Strategy of Transfusion in Trauma Patients - STATA Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

156

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
Wounds and Injuries
Interventions
OTHER

Blood Products only

Based solely on massive transfusion triggers Patients with traumatic hemorrhage that fulfil the inclusion criteria will receive blood products by prescription of the patient's anesthesiologist. The patient will be constantly observed and bleeding triggers will be reassessed hourly.

OTHER

Point of Care guided

Based on massive transfusion triggers and thromboelastometry Patients with traumatic hemorrhage that fulfil the inclusion criteria will receive the drugs guided by the results of the thromboelastometry. The dosis of each drug will be based on the analysis of the thromboelastometry curves (established algorithm).

Trial Locations (1)

05403-000

Hospital das Clínicas FMUSP, São Paulo

All Listed Sponsors
lead

University of Sao Paulo General Hospital

OTHER

NCT02416817 - Strategy of Transfusion in Trauma Patients - STATA Trial | Biotech Hunter | Biotech Hunter